Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy? (Q37797818)

From Wikidata
Jump to navigation Jump to search
scientific article published on 04 October 2010
edit
Language Label Description Also known as
English
Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy?
scientific article published on 04 October 2010

    Statements

    Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy? (English)
    Patrick J Roberts
    Thomas E Stinchcombe
    Channing J Der
    Mark A Socinski
    4 October 2010
    4769-4777

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit